Reproductive Health News and Research RSS Feed - Reproductive Health News and Research

CONRAD announces new funding agreement to increase HIV prevention products for high risk women in Africa

CONRAD announces new funding agreement to increase HIV prevention products for high risk women in Africa

CONRAD is pleased to announce a new funding agreement, in collaboration with the U.S. President's Emergency Plan for AIDS Relief and the U.S. Agency for International Development, in support of a human centered design (HCD) strategy to increase demand, use and adherence of HIV prevention products for high risk women in Africa. [More]
Kindara completes $5.3M in Seed funding

Kindara completes $5.3M in Seed funding

Kindara, a transformative women's health company that produces apps and devices that help women understand and achieve better results with their reproductive health, today announced the close of $5.3M in Seed funding, including the conversion of $1.9M in convertible notes. [More]
Even the Score issues statement on FDA approval of flibanserin for treatment of women with HSDD

Even the Score issues statement on FDA approval of flibanserin for treatment of women with HSDD

Even the Score issued the following statement following today's historic approval by the Food and Drug Administration of flibanserin (Addyi), the first-ever medical treatment option for women's most common sexual dysfunction, known as Hypoactive Sexual Desire Disorder (HSDD). [More]
Combination of chemotherapy and immune-blocking drug could prevent cancer recurrence

Combination of chemotherapy and immune-blocking drug could prevent cancer recurrence

Giving patients a drug that blocks part of the immune system from going into overdrive might help prevent cancer coming back in some people, according to research published today in Cancer Research. [More]
Population Council findings highlight strategies to delay child marriage

Population Council findings highlight strategies to delay child marriage

Today the Population Council released new evidence on what works to delay the age of marriage for extremely vulnerable girls in sub-Saharan Africa. Researchers also shared rarely available data on the cost of interventions that were tested, and issued recommendations for policymakers, donors, and organizations concerned about child marriage. [More]
Cycle Technologies launches new period-tracking and fertility app

Cycle Technologies launches new period-tracking and fertility app

Cycle Technologies today announced the launch of Dot, a period-tracking and fertility app based on the patent-pending Dynamic Optimal Timing (DOT) approach. This new family planning method accurately determines a woman's risk of pregnancy for each day of her cycle using just her period start dates. [More]
Elsevier selected to publish Journal of Obstetrics and Gynaecology Canada

Elsevier selected to publish Journal of Obstetrics and Gynaecology Canada

Elsevier, a world-leading provider of scientific, technical and medical information products and services, has announced that it has been selected by the Society of Obstetricians and Gynaecologists of Canada to publish its journal, Journal of Obstetrics and Gynaecology Canada, as of January 2016. [More]
BGI to hold 10th International Conference on Genomics in October

BGI to hold 10th International Conference on Genomics in October

The 10th International Conference on Genomics (ICG-10) will be held by BGI from October 22-25, 2015, in Shenzhen, China. [More]
WSU scientists suggest that glyphosate not present in human breast milk

WSU scientists suggest that glyphosate not present in human breast milk

Washington State University scientists have found that glyphosate, the main ingredient in the herbicide Roundup, does not accumulate in mother's breast milk. [More]
Georgetown's Institute for Reproductive Health receives $30 million from USAID to support Passages Project

Georgetown's Institute for Reproductive Health receives $30 million from USAID to support Passages Project

The U.S. Agency for International Development has awarded $30 million to Georgetown University Medical Center's Institute for Reproductive Health to fund its Passages Project, which aims to improve healthy timing and spacing of pregnancies among youth and first-time parents in developing countries. [More]
Research breakthrough opens door to a world of regenerative medicine for treating mitochondrial disease

Research breakthrough opens door to a world of regenerative medicine for treating mitochondrial disease

A study led by Shoukhrat Mitalipov, Ph.D., and Hong Ma, M.D., Ph.D., at the Center for Embryonic Cell and Gene Therapy at Oregon Health & Science University and the Oregon National Primate Research Center has revealed the first critical step in developing novel gene and stem cell therapy treatments for patients with mitochondrial disease. [More]
Researchers complete participants’ enrollment in Phase III trial of vaginal ring for HIV prevention

Researchers complete participants’ enrollment in Phase III trial of vaginal ring for HIV prevention

In a first for HIV prevention, an international team of researchers have completed follow-up of participants enrolled in a pivotal Phase III trial that tested the safety and effectiveness of a vaginal ring for preventing HIV in women. [More]
Caya contoured diaphragm to expand U.S. women's options for nonhormonal barrier contraception

Caya contoured diaphragm to expand U.S. women's options for nonhormonal barrier contraception

With the launch of the Caya contoured diaphragm this June, women in the United States will have access to a method of contraception that is nonhormonal, has few side effects, and can be used for up to two years. Last fall, the United States Food and Drug Administration cleared the single-size Caya contoured diaphragm for marketing in the US, and now the diaphragm is available by prescription from healthcare providers. [More]
WHO prequalifies new male circumcision device to prevent HIV

WHO prequalifies new male circumcision device to prevent HIV

The ShangRing, a novel medical device for voluntary medical male circumcision, has received prequalification from the World Health Organization (WHO) for use. [More]
Groundbreaking UVA research may lead to creation of male contraceptive

Groundbreaking UVA research may lead to creation of male contraceptive

Groundbreaking new reproductive research from the School of Medicine has identified key molecular events that could be playing a critical role as sperm and egg fuse to create new life. The findings might one day lead to the creation of a male contraceptive. [More]
Improved birth control advice reduces unintended pregnancy rate among young women

Improved birth control advice reduces unintended pregnancy rate among young women

Providing health workers with training on how to educate young women about intrauterine devices (IUDs) and contraceptive implants reduced the rate of unintended pregnancy by almost half in a study of women seeking family planning services. [More]
Study shows that women with endometriosis at increased risk of miscarriage, ectopic pregnancy

Study shows that women with endometriosis at increased risk of miscarriage, ectopic pregnancy

Women with endometriosis are at an increased risk of miscarriage and ectopic pregnancy, according to results of a huge nationwide study presented today. Moreover, women with a history of endometriosis whose pregnancies progressed beyond 24 weeks were found to be at a higher than average risk of complications, including haemorrhage (ante- and postpartum) and preterm birth. [More]
WHO's updated essential medicines list includes progesterone contraceptive vaginal ring

WHO's updated essential medicines list includes progesterone contraceptive vaginal ring

The World Health Organization released its 2015 updated essential medicines list and for the first time included the progesterone contraceptive vaginal ring (CVR), a contraceptive safe and effective for lactating women in the postpartum period. [More]
Findings could lead to new therapies that stop breast cancer progression

Findings could lead to new therapies that stop breast cancer progression

Scientists have discovered a trigger that allows breast cancer cells to spread to the lungs. They have found that blocking the signals in mice with breast cancer greatly reduces the number of secondary tumours found in the lungs. [More]
Merck KGaA, Darmstadt, Germany forms Global Fertility Alliance with Illumina and Genea

Merck KGaA, Darmstadt, Germany forms Global Fertility Alliance with Illumina and Genea

Merck KGaA, Darmstadt, Germany, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials today announced the formation of the Global Fertility Alliance, a new collaboration to advance excellence in fertility technologies and processes within the assisted reproductive treatment (ART) laboratory. [More]
Advertisement
Advertisement